1020 Locust Street
Jefferson Alumni Hall, Room 464
Philadelphia, PA 19107
(215) 503-4692
(215) 923 7144 fax
Jefferson Alumni Hall, Room 464
Philadelphia, PA 19107
(215) 503-4692
(215) 923 7144 fax
Most Recent Peer-reviewed Publications
- Intramuscular inoculation of mice with the live-attenuated recombinant rabies virus TriGAS results in a transient infection of the draining lymph nodes and a robust, long-lasting protective immune response against rabies
- Postexposure treatment with the live-attenuated rabies virus (rv) Vaccine trigas triggers the clearance of wild-type rv from the central nervous system (cns) Through the rapid induction of genes relevant to adaptive immunity in cns tissues
- The Role of Toll-Like Receptors in the Induction of Immune Responses During Rabies Virus Infection
- Oral immunization of raccoons and skunks with a canine adenovirus recombinant rabies vaccine
- Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans
- Immunogenicity and safety of recombinant rabies viruses used for oral vaccination of stray dogs and wildlife
- Effective preexposure and postexposure prophylaxis of rabies with a highly attenuated recombinant rabies virus
- Intravenous inoculation of a bat-associated rabies virus causes lethal encephalopathy in mice through invasion of the brain via neurosecretory hypothalamic fibers
- Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein gene
- Concepts in the pathogenesis of rabies
- Role of virus-induced neuropeptides in the brain in the pathogenesis of rabies
- The glycoprotein and the matrix protein of rabies virus affect pathogenicity by regulating viral replication and facilitating cell-to-cell spread
- Infection of monocytes or immature dendritic cells (DCs) with an attenuated rabies virus results in DC maturation and a strong activation of the NFκB signaling pathway
- Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines
- Dominance of a nonpathogenic glycoprotein gene over a pathogenic glycoprotein gene in rabies virus
- Highly attenuated rabies virus-based vaccine vectors expressing simian-human immunodeficiency virus89.6P Env and simian immunodeficiency virusmac239 Gag are safe in rhesus macaques and protect from an AIDS-like disease
- A single immunization with a recombinant canine adenovirus expressing the rabies virus G protein confers protective immunity against rabies in mice
- Rabies virus glycoprotein as a carrier for anthrax protective antigen
- Vaccination of small Asian mongoose (Herpestes javanicus) against rabies
- Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin